Sunitinib to Treat Recurrent Brain Cancer

Clinical trial NCT00923117 · TERMINATED

Trial details

NCT number: NCT00923117
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Malignant Gliomas Anaplastic Gliomas

Start date: 2008-06-01
Primary completion: 2012-06-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.